LONDON and DUBAI, UAE, May 4, 2023
/PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the
"Company") (Nasdaq: VRAX), an innovative diagnostics company
focused on the detection of immune responses to and diagnosis of
viral diseases, announced today that it established a regional
headquarters at Dubai Science Park, a member of TECOM Group
PJSC.
The office space is located in the heart of the global
science-focused community that enables research, innovation and
businesses in the health, energy, life sciences and environment
sectors. The new headquarters will accommodate the company's
expansion into the Middle East and
improve global operations by attracting local partnerships and
talents.
By entering the region, Virax Biolab Group aims to increase its
distribution reach of high-quality in-vitro diagnostics, innovative
products and proprietary T-Cell tests while creating logistical
efficiencies. The new headquarters will create new jobs and drive
investment and talent to the UAE in line with the Dubai Economic
Agenda 'D33'.
"The addition of a regional headquarters in Dubai Science Park
aligns perfectly with our mission to bring world-class testing
solutions for viral threats to additional geographies," said
James Foster, Virax's Chairman of
the Board of Directors and Chief Executive Officer. "The new
headquarters will strengthen the distribution network we have
developed for ViraxClear and enable further development of our
innovative technology behind Virax Immune, while tapping into an
esteemed science and business community established at Dubai
Science Park."
"We are excited to be a part of Dubai Science Park," said
Cameron Shaw, Virax's Chief
Operations Officer. "As a fast-growing company with a mission
to establish global reach and enhance immune health, we hope to
take advantage of the full spectrum of benefits at our disposal at
Dubai Science Park while contributing to an ecosystem that is
driving global change in business and healthcare."
Marwan Abdulaziz Janahi, Senior Vice President of Dubai
Science Park – TECOM Group, said: "Dubai's status as a global medical destination
has secured the trust of patients and healthcare service providers
alike. Innovative businesses are increasingly choosing our district
to expand operations to benefit the lives and treatment of
countless patients across the UAE and the region. We are delighted
to welcome Virax Biolabs Group to our fast-growing science
community. We are certain their cutting-edge detection and
treatment services will strengthen Dubai's healthcare ecosystem and help achieve
the vision of 'We The UAE 2031'."
Dubai Science Park is a global ecosystem that serves the entire
value chain of the science, health and pharma sectors. Home to
global MNEs, SMEs and start-ups, the hub contributes to
Dubai's knowledge and innovation
economy and its status as a medical tourism destination. Dubai
Science Park provides businesses with purpose-built infrastructure
to foster growth and access to markets across the UAE as well as
the MENA region.
Dubai Science Park is part of TECOM Group's portfolio of 10
districts that includes Dubai Internet City, Dubai Media City,
Dubai Studio City, Dubai Production City, Dubai Knowledge Park,
Dubai International Academic City, Dubai Design District (d3),
Dubai Industrial City and Dubai Outsource City.
About Virax Biolabs Group Limited.
Founded in
2013, Virax Biolabs Group Limited is an innovative
biotech company focused on the detection of immune responses to and
diagnosis of viral diseases.
In addition to distributing an array of in-vitro diagnostic test
kits, Virax Biolabs Group Limited is currently developing a
proprietary T-Cell Test technology with the intention of providing
an immunology profiling platform that assesses each individual's
immune risk profile against major global viral threats. T-Cell
testing can be particularly effective in the diagnosis and
therapeutics of COVID-19 as well as other threats including
Monkeypox, Hepatitis B, Malaria, Herpes and Human
Papillomavirus.
For more information, please
visit www.viraxbiolabs.com.
About Dubai Science Park
Founded in 2005, Dubai
Science Park is a vibrant, holistic community part of TECOM
Group PJSC dedicated to supporting customers in
the sciences, energy, and environmental sectors. With its ample
office and laboratory space and robust infrastructure, Dubai
Science Park has created an enabling science-focused ecosystem that
is home to major international, regional, and local
companies.
Through fostering growth, creativity, research, and innovation
in the areas of human science, plant science, material science,
environmental science and energy science, Dubai Science Park aims
to play a significant role in facilitating a more sustainable and
self-sufficient future that maximizes the use of indigenous
resources and talent.
For more information, please
visit www.dsp.ae
About TECOM Group PJSC
TECOM Group has been developing
strategic, sector-focused business districts across the emirate of
Dubai since 1999. TECOM Group is
well-positioned to continue playing an integral role in cementing
Dubai's status as a global
business and talent hub.
The TECOM Group portfolio consists of 10 business districts
catering to 6 vital knowledge-based economic sectors, including
design, education, manufacturing, media, science, and technology.
The Group provides a varied and tailor-made leasing portfolio –
which includes offices, co-working spaces, warehouses and land – to
over 9,500 customers and more than 105,000 professionals.
TECOM Group offers additional value-added services to deliver a
competitive and attractive environment for businesses and
entrepreneurs to thrive in and to facilitate engagement between the
districts' community members. Government and corporate services are
made available through an integrated smart services platform,
'axs', which enhances ease of doing business and provides community
members with a seamless experience.
TECOM Group also provides industry-specialised facilities,
including media production studios, laboratories and higher
education campuses. in5, its enabling platform for entrepreneurs
and start-ups, offers innovation centres supporting tech, media,
and design start-ups and SMEs. Its future-focused co-working spaces
D/Quarters deliver stimulating work environments for tenants, and
the 'GoFreelance' package serves freelancers.
Caution Concerning Forward Looking
Statements:
This press release contains
forward-looking statements. In addition, from time to time, we or
our representatives may make forward-looking statements orally or
in writing. We base these forward-looking statements on our
expectations and projections about future events, which we derive
from the information currently available to us. Such
forward-looking statements relate to future events or our future
performance, including: our financial performance and projections;
our growth in revenue and earnings; and our business prospects and
opportunities. You can identify forward-looking statements by those
that are not historical in nature, particularly those that use
terminology such as "may," "should," "expects," "anticipates,"
"contemplates," "estimates," "believes," "plans," "projected,"
"predicts," "potential," or "hopes" or the negative of these or
similar terms. In evaluating these forward-looking statements, you
should consider various factors, including: our ability to change
the direction of the Company; our ability to keep pace with new
technology and changing market needs; and the competitive
environment of our business. These and other factors may cause our
actual results to differ materially from any forward-looking
statement. Forward-looking statements are only predictions. The
forward-looking events discussed in this press release and other
statements made from time to time by us or our representatives, may
not occur, and actual events and results may differ materially and
are subject to risks, uncertainties, and assumptions about us.
These forward-looking statements are based on information currently
available to Virax and its current plans or
expectations and are subject to a number of known and unknown
uncertainties, risks and other important factors that may cause our
actual results, performance or achievements to be materially
different from any future results, performance or achievements
expressed or implied by the forward-looking statements. These and
other important factors are described in detail in the "Risk
Factors" section of Virax's Annual Report on Form 20-F
for the year ended March 31, 2022. Although we believe the
expectations reflected in such forward-looking statements are
reasonable, we can give no assurance that such expectations will
prove to be correct. We are not obligated to publicly update or
revise any forward-looking statement, whether as a result of
uncertainties and assumptions, the forward-looking events discussed
in this press release and other statements made from time to time
by us or our representatives might not occur.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/virax-biolabs-group-announces-establishment-of-regional-headquarters-at-dubai-science-park-301815818.html
SOURCE Virax Biolabs